|
|||||
| « Previous thread | Next thread » |
>From the BMY 10k the following two items have changes by a decent
margin. Any ideas why the large change?
Restricted stock
2006: (128)
2007: (97)
Percent change: 24.22%
Accumulated other comprehensive loss
2006: (1645)
2007: (1461)
Percent change: 11.19%
On Nov 11, 5:04 am, inetquestion <i...@h...com> wrote:
> >From the BMY 10k the following two items have changes by a decent
> margin. Any ideas why the large change?
>
Without having looked at the 10K, my guess is that some authorized
restricted stock was cashed in (or awarded and offset by new common -
I haven't looked up the details), thereby reducing the liability on
the balance sheets. The other item you noticed probably is offset by
reduction of assets, and is an accounting timing thing, matching to
periods and matching to actual dispositions. Or, if BMY had posted
losses, then its current accumulating earnings (retained) are reducing
the accumulated losses .
I believe drug companies are best analyzed by looking at the current
patent life of their products, the effects of expiration, and their
drug pipelines (new, pending tests and approvals).
| « Previous thread | Next thread » |
FROM THE MODERATORS: Lengthy posts
Big Slide in 401(k)s Spurs Calls for Change
Short-term Fund purchasing advice...
Criteria for choosing a bond fund?
FROM THE MODERATORS: Posting to misc.invest.financial-pl an
Anyone understand what's going on with GMAC?